Inventor
MOORE KEVIN W
US42 patents
⚠️ This page may combine multiple inventors who share the name “MOORE KEVIN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
30 patentsUS6756481B2Jun 29, 2004
IL-23 receptor binding compositions
SCHERING CORP103 citations98
US7422743B2Sep 9, 2008
Mammalian receptor protein DCRS5;methods of treatment
SCHERING CORP38 citations96
US7411041B2Aug 12, 2008
DCRS5 polypeptides
SCHERING CORP30 citations96
US5231012AJul 27, 1993
Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
SCHERING CORP126 citations96
US5789192AAug 4, 1998
Mammalian receptors for interleukin-10 (IL-10)
SCHERING CORP45 citations95
US6217857B1Apr 17, 2001
Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
SCHERING CORP62 citations94
US7754214B2Jul 13, 2010
Mammalian receptor protein DCRS5; methods of treatment
SCHERING CORP14 citations92
US7749718B2Jul 6, 2010
Method for raising or isolating an antibody to DCRS5
SCHERING CORP11 citations92
US7510853B2Mar 31, 2009
Nucleic acids encoding DCRS5
SCHERING CORP10 citations92
US5863796AJan 26, 1999
Antibodies which specifically bind mammalian receptors for interleukin-10 (IL-10)
SCHERING CORP24 citations92
US5776451AJul 7, 1998
Use of interleukin-10 in adoptive immunotherapy of cancer
SCHERING CORP29 citations92
US7893215B2Feb 22, 2011
Agonist antibodies to IL-23 receptor
SCHERING CORP17 citations89
US5827513AOct 27, 1998
Methods of treating insulin-dependent diabetes mellitus by administration of IL-10
SCHERING CORP19 citations88
US6018036AJan 25, 2000
Nucleic acids encoding cytokine synthesis inhibitory factor (Interleukin-10)
SCHERING CORP15 citations81
US6586228B1Jul 1, 2003
Polynucleotides encoding DIRS1
SCHERING CORP7 citations73
US5985828ANov 16, 1999
Mammalian receptors for interleukin-10 (IL-10)
SCHERING CORP6 citations73
US6239260B1May 29, 2001
Binding compositions specific for interleukin-10
SCHERING CORP8 citations72
US6207154B1Mar 27, 2001
Methods of treatment using antagonists of cytokine synthesis inhibitory factor
SCHERING CORP5 citations72
US6106823AAug 22, 2000
Treatment of neoplastic disease with interleukin-10
SCHERING CORP12 citations71
US5716804AFeb 10, 1998
Mammalian interleukin-10 (IL-10) super-activating receptors; and variants
SCHERING CORP12 citations68
US5840545ANov 24, 1998
Hybrid DNA prepared binding composition
SCHERING CORP1 citations63
US5736390AApr 7, 1998
BCRF1 proteins as inhibitors of interferon-γ
SCHERING CORP1 citations63
US6423500B1Jul 23, 2002
Mammalian receptors for interleukin-10
SCHERING CORP2 citations60
US6319493B1Nov 20, 2001
Treatment of neoplastic disease with interleukin-10
SCHERING CORP3 citations60
US7964703B2Jun 21, 2011
DCRS5 polypeptides
SCHERING CORP0 citations52
US7812126B2Oct 12, 2010
DIRS1 polypeptides
SCHERING CORP0 citations52
US7342103B2Mar 11, 2008
DIRS1 antibodies
SCHERING CORP0 citations52
US5851801ADec 22, 1998
Method of preparing polypeptide binding compositions derived from immunoglobulin variable regions
SCHERING CORP0 citations52
US5756342AMay 26, 1998
BCRF1 antagonists for treating epstein-barr virus infections
SCHERING CORP0 citations52
US5627155AMay 6, 1997
BCRF1 proteins as inhibitors of interferon-γ
SCHERING CORP1 citations52
DNAX RESEARCH INST OF MOLECULA
3 patentsUS4642334AFeb 10, 1987
Hybrid DNA prepared binding composition
DNAX RESEARCH INST OF MOLECULA210 citations98
US4749685AJun 7, 1988
Immunosuppressive peptides
DNAX RESEARCH INST OF MOLECULA3 citations61
US4758511AJul 19, 1988
CDNA clones coding for polypeptides exhibiting IGE binding factor activity
DNAX RESEARCH INST OF MOLECULA3 citations57